Madeline Colli

HYTN announces their new GMP Stability Program and the validation of their vape cartridges used in international markets.

Hemp Beverage Alliance disclosed recently their new Hemp Beverage Expo.

A recent press release announced a new development agreement between Neurotech and RH Pharma focused on cannabinoid therapies.

A recent study may show a potential connection between frequent cannabis use and cavities and tooth decay.

Artemis Growth Partners announced the first Global Cannabis Regulatory Summit taking place in March 2025.

Aurora Cannabis forms a supply agreement with SNDL.

Recently, the Institute of Cannabis Research at Colorado State University Pueblo sequenced the whole genome of a new cannabis strain called Pink Pepper.

Willow Industries and Abstrax announce new cannabis terpene infusion system called HALO.

In honor of National Hemp Day on February 4, 2025, we are excited to share with you our hemp-themed round up of hemp research.

Check out our exciting 2025 National Hemp Day coverage!

In honor of National Hemp Day on February 4, 2025, we are excited to share with you our hemp-themed round up of Federal hemp regulations.

In honor of National Hemp Day, Cannabis Science and Technology has compiled a hemp-themed round up of Kim Anzarut's Stuck on Compliance blog.

Yale researchers investigated in a recent study how cannabinoids can be used as an alternative chronic pain treatment without addiction risks and found that they can help lower pain signals in Nav1.8.

Researchers analyzed data in a recent study, looking to examine how various levels of cannabis use effects brain function.

Metrc recently announced that they signed a new government contract with the US Virgin Islands for their new track-and-trace platform.

Raw Garden announced recently that the company is looking to obtain their ECCO certification.

Adam Goers, SVP of Corporate Affairs for The Cannabist Company and the co-chair of the Coalition for Cannabis Scheduling Reform (CCSR), discusses the recent cancellation of the DEA cannabis rescheduling hearing, how this delay could be strategic and necessary to ensure a legitimate outcome that may benefit the interested parties seeking the rescheduling.

The FDA is seeking commentary from the public regarding the use of cannabis-derived products such as CBD, in veterinary practice.

Cannabix Technologies Inc. reveals new advancements in cannabis use detecting breathalyzer technology.

DEA Judge John Mulrooney II cancels upcoming cannabis rescheduling hearing, postponing cannabis reform.

DoorDash in certain states is now offering on-demand delivery of hemp-derived THC and CBD products.

Blimburn Seeds announced recently their expansion in the United States.

A new bill was introduced to California’s state assembly which would allow hemp-derived products with limited quantities of THC, alleviating the previous ban.

A market report on hemp-derived CBD’s growing interest to be used in personal care and cosmetics, regulatory changes and natural and plant-based wellness products.

A recent study revealed the potential use of CBD to help decrease alcohol use disorder cravings.

New York Governor Kathy Hochul recently announced that the Big Apple recently reached $1 billion in cannabis retail sales.

Louisiana rings in the new year with new THC and CBD legislation for both the cannabis and hemp industries.

Lowtemp Industries announced their new concentrate dispenser technology which raises cannabis extracts packaging efficiency by over 800%.

As bat guano becomes more commonly used in cannabis cultivation, a recent study highlights the negative effects that can come with using this type of fertilizer.

With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election, including state and federal policies and possible paths forward for testing standardization. Join us in the second part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.